Newsletter Subject

Futures Rise on Upbeat MSFT Earnings 📈

From

elitetrade.club

Email Address

adam@elitetrade.club

Sent On

Wed, Apr 26, 2023 11:54 AM

Email Preheader Text

Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarke

[Image](www.elitetrade.club) Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Today is Wednesday, April 26th. I hope you have a great day. Now, let's get ready to trade! Markets 📈 Results from First Republic Bank and other major companies sent US benchmarks tumbling on Tuesday. The Dow fell 1.0%, while the S&P 500 lost 1.5%, and the Nasdaq tumbled to a 1.9% loss. The small-cap Russell 2K underperformed with a 2.4% decline. Futures are on the rise after Microsoft released strong earnings results on Tuesday evening. S&P 500 contracts are currently up 0.1%. Sponsored [A Crash Proof Portfolio?]( If you're worried "transitory" inflation and "mild" recession will be worse than expected... You're not alone. BUT one asset 99% of investors miss helps protect your portfolio and has outpaced the S&P by 131% over the past 26 years. Art. Historically, you've needed millions to invest, but one platform lets you buy shares in famous paintings for as little as $20! [Skip the waitlist and join Masterworks today with this private link.]( Premarket Highlights 🔎 📈 Microsoft Earnings Boost Stocks Upbeat earnings results from Microsoft put the market in an exuberant mood coming into today's session. The tech giant reported stronger-than-expected figures for earnings and revenues. What to Watch Today? 👀 Meta Earnings Investors are keeping a close eye on tech earnings, and Meta is the next big name to report. The Facebook parent company is expected to report its fourth-straight quarter of declining sales, as difficulties for the company continue. However, today's earnings report could shed more light on the outlook for the company in 2023 & beyond. Major Earnings 💰 Thermo Fisher Scientific Inc [TMO] ... AM Boeing Company (The) [BA] ... AM American Tower Corporation (Reit) Reit [AMT] ... AM Automatic Data Processing, Inc. [ADP] ... AM Boston Scientific Corporation [BSX] ... AM Cme Group Inc. [CME] ... AM Humana Inc. [HUM] ... AM Meta Platforms, Inc. [META] ... PM Servicenow, Inc. [NOW] ... PM Waste Management, Inc. [WM] ... PM Economy 🏗 - Durable-goods orders [Mar] ... 8:30a - Advanced U.S. trade balance in goods [Mar] ... 8:30a - Advanced retail inventories [Mar] ... 8:30a - Advanced wholesale inventories [Mar] ... 8:30a Running Hot 🔥 Gainers - Clearmind Medicine [CMND] >> +43.3% - SAITECH Global [SAI] >> +24.9% - Homology Medicines [FIXX] >> +19.7% Decliners - Zyversa Therapeutics [ZVSA] >> (40.9%) - Bed Bath & Beyond [BBBY] >> (25.2%) - Enphase Energy [ENPH] >> (16.5%) Microsoft [MSFT] - Last Close: $43.53 Microsoft is rallying after a strong earnings report. The tech giant reported earnings and revenues that stopped analyst expectations, and investors are optimistic about the company's plans for AI. Microsoft generated EPS of $2.45 per share on revenues of $52.9 billion, which topped the consensus of $2.23 per share on $51.02 billion. The company reported lower-than-expected growth estimates for its lucrative Azure segment, but the market took the news well. The news prompted several analyst upgrades. However, news just broke that UK regulators blocked the firm's planned acquisition of Activision Blizzard [ATVI]. MSFT is up 7.4% in the premarket and leading the S&P 500. My Take: MSFT is getting a big boost from its ChatGPT deal and other AI efforts. There could be more gains ahead for this stock. IN8bio [INAB] - Last Close: $1.91 A regulatory ruling is giving IN8bio a big boost. Early this morning, the biotech company said the Food & Drug Administration awarded an Orphan Drug Designation for INB-400 & INB-410. The designations cover treatment for a broad range of malignant tumors, including newly diagnosed glioblastoma. IN8bio said it expects to begin patient enrollment for a phase 2 trial of INB-400 expected to begin in the second half. The news rallied INAB to a 41.3% gain in the premarket. My Take: INAB has made dramatic moves in the past two days. It will be interesting to see which way it goes over the next few days. Sobr Safe [SOBR] - Last Close: $1.69 Sobr Safe is moving higher after an early-morning product announcement. The non-invasive alcohol detection firm announced a new partnership with Think Twice to advocate for its SOBRsafe technology to enterprise employers. Think Twice supplies public safety products and programs through the U.S. and Canada, with over 5,000 customers across numerous industries. Under the terms of the agreement, Think Twice will encourage its customers to drop traditional breathalyzers in favor of SOBRsafe. SOBR is up 20.7% following the early morning announcements. My Take: SOBR has made some progress lately, and the market seems to be buying into its new technology. This stock could have some promise. Panbela Therapeutics [PBLA] - Last Close: $0.42 An analyst rating is rallying shares of Panbela Therapeutics. HC Wainwright & Co analyst Joseph Pantginis initiated coverage on the clinical-stage biopharma firm with a "buy" rating and a $7 price target. The note dropped this morning, and the news immediately sparked a run up in shares of PBLA. PBLA is up 17.9%, and it's one of the top-performing NASDAQ stocks. My Take: PBLA's chart is very unimpressive, but this analyst rating could be a good start for the stock. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. [Bots click here]( 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](

Marketing emails from elitetrade.club

View More
Sent On

08/12/2024

Sent On

07/12/2024

Sent On

06/12/2024

Sent On

06/12/2024

Sent On

03/12/2024

Sent On

03/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.